tirzepatide and binge eating disorder The STRAND Project: Are you

Expert-guided treatments for a healthier you.

Lake City, FL

Discover how a wave of semaglutide biosimilars could impact Mainland Chinas healthcare market, from pricing to accessibility and competition.

Recently, it has become popular as a potential weight loss aid.

Please inclu...

Phase 3 Results (REIMAGINE-2, Feb 2026): HbA1c reduction of up to 1.91 points, outperforming semaglutide alone Weight loss of up to 14.2% at 68 weeks in adults with type 2 diabetes and obesity In weight-management evaluation, diabetics achieved ~15.7% weight loss vs 3.1% with placebo Regulatory update: Novo Nordisk filed for FDA approval (Dec 2025) for weight management, supported by the REDEFINE clinical program